XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.30%1.79B | 3.60%457.79M | -1.72%443.26M | -4.68%450.27M | -2.14%436.38M | 0.62%1.81B | -1.13%441.89M | -1.41%451M | 4.16%472.36M | 0.86%445.92M |
Operating revenue | -1.30%1.79B | 3.60%457.79M | -1.72%443.26M | -6.03%393.6M | -2.14%436.38M | 0.62%1.81B | -1.13%441.89M | -1.41%451M | 3.37%418.83M | 0.86%445.92M |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 0.88%1.52B | 0.34%385.74M | 2.04%387.67M | 2.26%377.63M | -1.10%372.78M | -0.10%1.51B | 1.49%384.43M | -1.39%379.92M | -0.96%369.3M | 0.47%376.93M |
Selling and administrative expenses | -8.82%148.52M | -20.42%36.64M | -0.91%35.51M | -2.37%38.48M | -8.89%37.9M | 21.80%162.88M | 46.44%46.04M | 22.84%35.84M | 23.53%39.41M | 0.92%41.6M |
-General and administrative expense | -8.82%148.52M | -20.42%36.64M | -0.91%35.51M | -2.37%38.48M | -8.89%37.9M | 21.80%162.88M | 46.44%46.04M | 22.84%35.84M | 23.53%39.41M | 0.92%41.6M |
Depreciation amortization depletion | 3.05%447.5M | 2.60%113.06M | 5.13%116.01M | 2.44%109.77M | 1.96%108.66M | -13.92%434.27M | -17.68%110.2M | -17.97%110.35M | -9.69%107.16M | -9.26%106.57M |
-Depreciation and amortization | 3.05%447.5M | 2.60%113.06M | 5.13%116.01M | 2.44%109.77M | 1.96%108.66M | -13.92%434.27M | -17.68%110.2M | -17.97%110.35M | -9.69%107.16M | -9.26%106.57M |
Provision for doubtful accounts | --0 | ---- | ---- | ---- | ---- | --8.27M | ---- | ---- | ---- | ---- |
Other operating expenses | 2.50%927.8M | 7.33%236.04M | 1.03%236.15M | 2.99%229.38M | -1.11%226.22M | 3.58%905.16M | 3.02%219.93M | 5.48%233.74M | 0.19%222.72M | 5.65%228.77M |
Operating profit | -12.21%263.87M | 25.40%72.05M | -21.78%55.59M | -29.52%72.64M | -7.82%63.6M | 4.42%300.58M | -15.70%57.46M | -1.48%71.07M | 27.84%103.06M | 3.06%68.99M |
Net non-operating interest income expense | -15.03%-344.25M | -21.33%-89.2M | -17.64%-88.45M | -18.80%-87.81M | -2.81%-78.79M | -15.14%-299.26M | 5.32%-73.52M | -5.10%-75.19M | -24.00%-73.91M | -50.00%-76.63M |
Non-operating interest income | -7.90%46.02M | -20.40%11.28M | -3.72%12.45M | -20.06%10.6M | 21.72%11.69M | 151.48%49.97M | 33.88%14.17M | 147.40%12.93M | 336.59%13.26M | 843.32%9.6M |
Non-operating interest expense | 13.02%368.35M | 15.65%95.24M | 16.38%95.59M | 13.76%92.39M | 6.11%85.13M | 26.35%325.92M | -0.18%82.36M | 15.46%82.13M | 42.37%81.21M | 69.67%80.22M |
Total other finance cost | -5.91%21.92M | -1.87%5.24M | -11.26%5.32M | 0.99%6.01M | -11.01%5.35M | 6.87%23.3M | -6.95%5.34M | 6.31%6M | 6.34%5.95M | 24.54%6.01M |
Other net income (expense) | 102.71%123.22M | 137.72%28.73M | -75.75%18.28M | 59.03%60.55M | -33.38%15.66M | 115.63%60.79M | 85.02%-76.17M | 224.42%75.38M | -25.99%38.08M | -47.68%23.51M |
Gain on sale of security | -102.96%-47K | 190.28%65K | -103.48%-62K | 16.67%-85K | 284.21%35K | -55.10%1.59M | 96.17%-72K | 1,706.31%1.78M | 28.17%-102K | -100.33%-19K |
Earnings from equity interest | 190.69%112.46M | 189.53%30.01M | -0.22%18.23M | 28.65%47.95M | -2.32%16.28M | 108.39%38.69M | 93.85%-33.52M | -24.95%18.27M | 44.91%37.27M | -50.57%16.67M |
Special income (charges) | -47.31%10.81M | 96.85%-1.34M | -99.80%113K | 1,300.33%12.69M | -109.52%-653K | -70.24%20.51M | -210.66%-42.58M | 5,654.52%55.32M | -96.50%906K | 23.71%6.86M |
-Less:Restructuring and merger&acquisition | -7.78%5.24M | -67.94%1.34M | -113.90%-113K | 11,103.33%3.36M | -0.76%653K | -54.97%5.68M | -45.41%4.18M | -18.37%813K | -98.99%30K | -34.53%658K |
-Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | 135.66%45.01M | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | -77.46%16.05M | --0 | --0 | 1,614.53%16.05M | --0 | -29.24%71.2M | -89.87%6.61M | --56.14M | -96.75%936K | 14.77%7.52M |
Income before tax | -31.02%42.85M | 112.55%11.58M | -120.47%-14.59M | -32.50%45.38M | -97.06%467K | 117.21%62.11M | 82.19%-92.24M | 199.10%71.25M | -7.23%67.23M | -73.90%15.87M |
Income tax | -22.22%22.73M | -30.48%5.82M | -58.21%4.88M | 17.50%5.28M | 44.42%6.74M | 34.91%29.22M | 20.07%8.37M | 214.85%11.68M | 26.18%4.5M | -37.03%4.67M |
Net income | -38.83%20.12M | 105.72%5.76M | -132.68%-19.47M | -36.08%40.1M | -156.02%-6.27M | 108.60%32.89M | 80.84%-100.61M | 196.19%59.57M | -8.95%62.73M | -79.02%11.2M |
Net income continuous Operations | -38.83%20.12M | 105.72%5.76M | -132.68%-19.47M | -36.08%40.1M | -156.02%-6.27M | 108.60%32.89M | 80.84%-100.61M | 196.19%59.57M | -8.95%62.73M | -79.02%11.2M |
Minority interest income | 30.76%-50.27M | 80.10%-10.97M | -79.92%-15.84M | -1,392.62%-10.69M | -34.41%-12.77M | -101.05%-72.61M | -16.67%-55.13M | -176.37%-8.81M | -72.02%827K | -183.56%-9.5M |
Net income attributable to the parent company | -33.28%70.39M | 136.78%16.73M | -105.30%-3.63M | -17.96%50.79M | -68.62%6.5M | 130.45%105.49M | 90.48%-45.48M | 193.48%68.38M | -6.13%61.91M | -50.73%20.7M |
Preferred stock dividends | -0.01%62.11M | -0.02%15.53M | -0.01%15.53M | 0.00%15.53M | 0.00%15.53M | 0.00%62.12M | 0.00%15.53M | 0.00%15.53M | 0.00%15.53M | 0.00%15.53M |
Other preferred stock dividends | 0 | 0 | -75.00%1K | -80.00%1K | ||||||
Net income attributable to common stockholders | -80.92%8.28M | 101.97%1.2M | -136.25%-19.15M | -23.97%35.26M | -274.81%-9.03M | 110.62%43.38M | 87.63%-61.01M | 580.55%52.85M | -8.01%46.38M | -80.48%5.17M |
Basic earnings per share | -82.61%0.04 | 103.13%0.01 | -135.71%-0.1 | -20.83%0.19 | -266.67%-0.05 | 110.80%0.23 | 87.55%-0.32 | 600.00%0.28 | -7.69%0.24 | -78.57%0.03 |
Diluted earnings per share | -82.61%0.04 | 103.13%0.01 | -135.71%-0.1 | -25.00%0.18 | -266.67%-0.05 | 110.80%0.23 | 87.55%-0.32 | 600.00%0.28 | -7.69%0.24 | -78.57%0.03 |
Dividend per share | 9.63%0.74 | 146.67%0.74 | 0 | 0 | 0 | -68.16%0.675 | -43.40%0.3 | 0 | 0 | -29.25%0.375 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |